156 related articles for article (PubMed ID: 18991620)
1. HIV pharmacogenetics in clinical practice: recent achievements and future challenges.
Tozzi V; Libertone R; Liuzzi G
Curr HIV Res; 2008 Nov; 6(6):544-54. PubMed ID: 18991620
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of antiretrovirals.
Tozzi V
Antiviral Res; 2010 Jan; 85(1):190-200. PubMed ID: 19744523
[TBL] [Abstract][Full Text] [Related]
3. [Applicability of pharmacogenetic studies in daily clinical practice].
Iribarren Loyarte JA
Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():45-54. PubMed ID: 18680696
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of anti-HIV drugs.
Telenti A; Zanger UM
Annu Rev Pharmacol Toxicol; 2008; 48():227-56. PubMed ID: 17883329
[TBL] [Abstract][Full Text] [Related]
5. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
6. Will pharmacogenomic discoveries improve HIV therapeutics?
Haas DW
Top HIV Med; 2005; 13(3):90-5. PubMed ID: 16170225
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update.
Cressey TR; Lallemant M
Infect Genet Evol; 2007 Mar; 7(2):333-42. PubMed ID: 17045554
[TBL] [Abstract][Full Text] [Related]
8. The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.
Michaud V; Bar-Magen T; Turgeon J; Flockhart D; Desta Z; Wainberg MA
Pharmacol Rev; 2012 Jul; 64(3):803-33. PubMed ID: 22759796
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and the potential for the individualization of antiretroviral therapy.
Phillips EJ; Mallal SA
Curr Opin Infect Dis; 2008 Feb; 21(1):16-24. PubMed ID: 18192781
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of HIV therapy.
Owen A; Pirmohamed M; Khoo SH; Back DJ
Pharmacogenet Genomics; 2006 Oct; 16(10):693-703. PubMed ID: 17001288
[TBL] [Abstract][Full Text] [Related]
11. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
Lucas A; Nolan D; Mallal S
J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbidities.
Haas DW; Tarr PE
Curr Opin HIV AIDS; 2015 Mar; 10(2):116-22. PubMed ID: 25565175
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.
Vidal F; Domingo P; Viladés C; Peraire J; Arnedo M; Alcamí J; Leal M; Villarroya F; Gatell JM
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1365-82. PubMed ID: 21999362
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics.
Arab-Alameddine M; Décosterd LA; Buclin T; Telenti A; Csajka C
Expert Opin Drug Metab Toxicol; 2011; 7(5):609-22. PubMed ID: 21500966
[TBL] [Abstract][Full Text] [Related]
15. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
Manfredi R; Calza L
AIDS Patient Care STDS; 2008 Apr; 22(4):279-90. PubMed ID: 18290748
[TBL] [Abstract][Full Text] [Related]
16. Efavirenz and nevirapine in HIV-1 infection : is there a role for clinical pharmacokinetic monitoring?
Dahri K; Ensom MH
Clin Pharmacokinet; 2007; 46(2):109-32. PubMed ID: 17253884
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?
Nolan D; Gaudieri S; Mallal S
J HIV Ther; 2003 May; 8(2):36-41. PubMed ID: 12838163
[TBL] [Abstract][Full Text] [Related]
18. [Toxicogenetics of antiretroviral treatment (II): neurotoxicity, hepatotoxicity, lactic acidosis, kidney damage, and other adverse effects of antiretroviral drugs].
Sánchez Hellín V; Gutiérrez Rodero F
Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 6():24-33. PubMed ID: 18680693
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of adverse effects due to antiretroviral drugs.
Vidal F; Gutiérrez F; Gutiérrez M; Olona M; Sánchez V; Mateo G; Peraire J; Viladés C; Veloso S; López-Dupla M; Domingo P
AIDS Rev; 2010; 12(1):15-30. PubMed ID: 20216907
[TBL] [Abstract][Full Text] [Related]
20. Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.
Guo Y; Shi L; Hong H; Su Z; Fuscoe J; Ning B
Sci China Life Sci; 2013 Feb; 56(2):119-24. PubMed ID: 23393027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
